Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.370
+0.070 (5.38%)
At close: Nov 7, 2025, 4:00 PM EST
1.380
+0.010 (0.73%)
After-hours: Nov 7, 2025, 7:48 PM EST
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $96.86 million as of November 7, 2025. Its market cap has decreased by -76.35% in one year.
Market Cap
96.86M
Enterprise Value
57.10M
1-Year Change
-76.35%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $96.86M, a decrease of -80.19%. That is a compound annual growth rate of -29.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 96.86M | -31.11% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |